Microalgal co-cultivation -recent methods, trends in omic-studies, applications, and future challenges.

The burgeoning human population has resulted in an augmented demand for raw materials and energy sources, which in turn has led to a deleterious environmental impact marked by elevated greenhouse gas (GHG) emissions, acidification of water bodies, and escalating global temperatures. Therefore, it is imperative that modern society develop sustainable technologies to avert future environmental degradation and generate alternative bioproduct-producing technologies. A promising approach to tackling this challenge involves utilizing natural microbial consortia or designing synthetic communities of microorganisms as a foundation to develop diverse and sustainable applications for bioproduct production, wastewater treatment, GHG emission reduction, energy crisis alleviation, and soil fertility enhancement.

Beneficial effects of seaweed-derived components on metabolic syndrome via gut microbiota modulation.

Metabolic syndrome comprises a group of conditions that collectively increase the risk of abdominal obesity, diabetes, atherosclerosis, cardiovascular diseases, and cancer. Gut microbiota is involved in the pathogenesis of metabolic syndrome, and microbial diversity and function are strongly affected by diet. In recent years, epidemiological evidence has shown that the dietary intake of seaweed can prevent metabolic syndrome via gut microbiota modulation.

The Potential of in Bioremediation of Antibiotics: Performance and Optimization.

Antibiotics are frequently applied to treat bacterial infections in humans and animals. However, most consumed antibiotics are excreted into wastewater as metabolites or in their original form. Therefore, removal of antibiotics from aquatic environments is of high research interest.

Removal of Pharmaceutical Micropollutants with Integrated Biochar and Marine Microalgae.

Using microalgae to remove pharmaceuticals and personal care products (PPCPs) micropollutants (MPs) have attracted considerable interest. However, high concentrations of persistent PPCPs can reduce the performance of microalgae in remediating PPCPs. Three persistent PPCPs, namely, carbamazepine (CBZ), sulfamethazine (SMT) and tramadol (TRA), were treated with a combination of and biochar in a photobioreactor during this study.